Literature DB >> 9152415

A recombinant human adenovirus expressing the simian immunodeficiency virus Gag antigen can induce long-lived immune responses in mice.

B Flanagan1, C R Pringle, K N Leppard.   

Abstract

Human adenovirus type 5 can be used as a vector to elicit immune responses to antigens expressed from heterologous DNA sequences incorporated into the viral genome, for example in mice immunized intraperitoneally. We have used a recombinant adenovirus which expresses the p55gag antigen of simian immunodeficiency virus to evaluate the nature and longevity of the response elicited when administered to mice by alterative routes which translate more readily to larger animals and man. In C57BI/6 mice immunized orally with a single dose of virus, a majority of the animals which showed evidence of responding to the immunogen by producing an anti-adenovirus response also produced a plasma antibody response to Gag which persisted for more than 1 year and a Gag-specific cytotoxic T cell response that could be detected for at least 6 months. In a minority of similarly immunized responding animals, only a cytotoxic response to Gag was observed although both humoral and cellular responses to adenovirus antigens were seen; intranasal immunization produced a Gag-specific response similar to this latter pattern. These findings suggest that delivery of adenovirus recombinants orally or intranasally may be a useful strategy for eliciting long-term cytotoxic T cell memory responses in splenocytes to candidate vaccine antigens.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9152415     DOI: 10.1099/0022-1317-78-5-991

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  5 in total

1.  New pre-pandemic influenza vaccines: an egg- and adjuvant-independent human adenoviral vector strategy induces long-lasting protective immune responses in mice.

Authors:  M A Hoelscher; L Jayashankar; S Garg; V Veguilla; X Lu; N Singh; J M Katz; S K Mittal; S Sambhara
Journal:  Clin Pharmacol Ther       Date:  2007-10-24       Impact factor: 6.875

2.  Both mucosal and systemic routes of immunization with the live, attenuated NYVAC/simian immunodeficiency virus SIV(gpe) recombinant vaccine result in gag-specific CD8(+) T-cell responses in mucosal tissues of macaques.

Authors:  Liljana Stevceva; Xavier Alvarez; Andrew A Lackner; Elzbieta Tryniszewska; Brian Kelsall; Janos Nacsa; Jim Tartaglia; Warren Strober; Genoveffa Franchini
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

3.  Induction of CD8 T cells by vaccination with recombinant adenovirus expressing human papillomavirus type 16 E5 gene reduces tumor growth.

Authors:  D W Liu; Y P Tsao; C H Hsieh; J T Hsieh; J T Kung; C L Chiang; S J Huang; S L Chen
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

4.  Oral immunization of rhesus macaques with adenoviral HIV vaccines using enteric-coated capsules.

Authors:  George T Mercier; Pramod N Nehete; Marco F Passeri; Bharti N Nehete; Eric A Weaver; Nancy Smyth Templeton; Kimberly Schluns; Stephanie S Buchl; K Jagannadha Sastry; Michael A Barry
Journal:  Vaccine       Date:  2007-11-05       Impact factor: 3.641

5.  Dendritic cells genetically modified with an adenovirus vector encoding the cDNA for a model antigen induce protective and therapeutic antitumor immunity.

Authors:  W Song; H L Kong; H Carpenter; H Torii; R Granstein; S Rafii; M A Moore; R G Crystal
Journal:  J Exp Med       Date:  1997-10-20       Impact factor: 14.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.